AmeriFlex Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$910K Buy
759
+41
+6% +$41.9K 0.37% 58
2026
Q1
$660K Sell
718
-130
-15% -$132K 0.33% 65
2025
Q4
$911K Sell
848
-77
-8% -$73.6K 0.47% 39
2025
Q3
$705K Sell
925
-245
-21% -$182K 0.26% 75
2025
Q2
$930K Buy
1,170
+52
+5% +$40.4K 0.49% 47
2025
Q1
$923K Buy
1,118
+649
+138% +$540K 0.38% 58
2024
Q4
$381K Buy
+469
New +$388K 0.17% 127

Other funds holding LLY

AmeriFlex Group's LLY Position: Q2 2026 in Review

AmeriFlex Group increased its Eli Lilly (LLY) stake by 5.7% in Q2 2026, buying an estimated $41.9K and bringing the position to 759 shares worth $910K. The position accounts for 0.37% of the portfolio, ranked #58.

AmeriFlex Group first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $930K in Q2 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • AmeriFlex Group held 759 shares of Eli Lilly worth $910K as of Q2 2026.
  • AmeriFlex Group bought 41 Eli Lilly shares in Q2 2026, an estimated $41.9K.
  • Eli Lilly made up 0.37% of AmeriFlex Group's portfolio in Q2 2026, its #58 holding.
  • AmeriFlex Group first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's Eli Lilly position peaked at $930K in Q2 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.